COX-2 gene expression is correlated with cognitive function in recurrent depressive disorder

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Recurrent depressive disorder (rDD) is associated with cognitive impairments.
• Inflammation is increasingly recognized as a factor in major depressive disorder.
• Cyclooxygenase-2 (COX-2) is a key enzyme in inflammatory pathways.

Purpose of the Study:

• To investigate the role of COX-2 in recurrent depressive disorder (rDD).
• To examine the association between COX-2 expression and cognitive functions in rDD patients.

Main Methods:

• Assessed COX-2 expression levels in patients with rDD and control subjects.
• Correlated COX-2 expression with measures of cognitive function in both groups.

Main Results:

• Significantly higher COX-2 expression was observed in the rDD group compared to controls.
• A significant negative correlation was found between COX-2 expression and cognitive functions in patients with rDD.
• No significant association between COX-2 expression and cognitive functions was found in the control group.

Conclusions:

• COX-2 may be a key inflammatory enzyme implicated in the pathophysiology of rDD.
• COX-2 expression levels are associated with cognitive deficits observed in recurrent depressive disorder.
• Targeting COX-2 pathways could be a potential therapeutic strategy for cognitive dysfunction in rDD.